Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Vigorito

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2008
Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host diseaseMary E D Flowers, Barry Storer, Paul Carpenter, et al.
Bone Marrow Transplantation|October 28, 2003
Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejectionF L Dulley, A C Vigorito, F J P Aranha, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|May 16, 2002
Correlation of mixed lymphocyte culture with chronic graft-versus-host disease following allogeneic stem cell transplantationJ E L Visentainer, S R Lieber, L B L Persoli, et al.
Acta Haematologica|January 21, 2006
Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non-Hodgkin's lymphoma patients: a prospective randomized GEMOH reportR C Baldissera, M Nucci, A C Vigorito, et al.
Clinical Lymphoma & Myeloma|December 3, 2009
Brazilian experience using high-dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for relapsed or refractory Hodgkin lymphomaBruno K L Duarte, Isabella Valente, Afonso C Vigorito, et al.
Scandinavian Journal of Immunology|November 21, 2007
IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantationD O Viel, L T Tsuneto, C R Sossai, et al.
Oral Diseases|October 21, 2020
Oral shedding of CMV and HSV-1 in hematopoietic stem cell transplantation patientsAndre L F Costa, Bruna A Santos, Vinicius R Torregrossa, et al.
BMC Infectious Diseases|July 12, 2013
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantationDébora C Dieamant, Sandra H A Bonon, Renata M B Peres, et al.
Physical Review Letters|September 26, 2012
Measurement of the velocity of neutrinos from the CNGS beam with the large volume detectorN Yu Agafonova, M Aglietta, P Antonioli, et al.
Transplantation and Cellular Therapy|June 29, 2026
Comparison of Carmustine-, Lomustine-, and Nitrosourea-free Conditioning Regimens for Autologous Hematopoietic Cell Transplantation in Lymphoma (auto-HTC): Results from the Hematopoietic Cell Transplantation Brazilian Registry (HCTBR)Abrahão Elias Hallack Neto, Vanderson Rocha, Eliana Miranda, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2008
Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host diseaseMary E D Flowers, Barry Storer, Paul Carpenter, et al.
Bone Marrow Transplantation|October 28, 2003
Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejectionF L Dulley, A C Vigorito, F J P Aranha, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|May 16, 2002
Correlation of mixed lymphocyte culture with chronic graft-versus-host disease following allogeneic stem cell transplantationJ E L Visentainer, S R Lieber, L B L Persoli, et al.
Acta Haematologica|January 21, 2006
Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non-Hodgkin's lymphoma patients: a prospective randomized GEMOH reportR C Baldissera, M Nucci, A C Vigorito, et al.
Clinical Lymphoma & Myeloma|December 3, 2009
Brazilian experience using high-dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for relapsed or refractory Hodgkin lymphomaBruno K L Duarte, Isabella Valente, Afonso C Vigorito, et al.
Scandinavian Journal of Immunology|November 21, 2007
IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantationD O Viel, L T Tsuneto, C R Sossai, et al.
Oral Diseases|October 21, 2020
Oral shedding of CMV and HSV-1 in hematopoietic stem cell transplantation patientsAndre L F Costa, Bruna A Santos, Vinicius R Torregrossa, et al.
BMC Infectious Diseases|July 12, 2013
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantationDébora C Dieamant, Sandra H A Bonon, Renata M B Peres, et al.
Physical Review Letters|September 26, 2012
Measurement of the velocity of neutrinos from the CNGS beam with the large volume detectorN Yu Agafonova, M Aglietta, P Antonioli, et al.
Transplantation and Cellular Therapy|June 29, 2026
Comparison of Carmustine-, Lomustine-, and Nitrosourea-free Conditioning Regimens for Autologous Hematopoietic Cell Transplantation in Lymphoma (auto-HTC): Results from the Hematopoietic Cell Transplantation Brazilian Registry (HCTBR)Abrahão Elias Hallack Neto, Vanderson Rocha, Eliana Miranda, et al.
Pageof 14